Zhengzhou Key Laboratory of Medicinal Resources Research, Huanghe Science and Technology College, Zhengzhou 450063, China.
Henan Joint International Research Laboratory of Drug Discovery of Small Molecules, Zhengzhou 450063, China.
Biomed Res Int. 2020 Dec 1;2020:6940953. doi: 10.1155/2020/6940953. eCollection 2020.
Plumbagin (PLB), a natural naphthoquinone constituent isolated from the roots of the medicinal plant L., exhibited anticancer activity against a variety of cancer cell lines including breast cancer, hepatoma, leukemia, melanoma, prostate cancer, brain tumor, tongue squamous cell carcinoma, esophageal cancer, oral squamous cell carcinoma, lung cancer, kidney adenocarcinoma, cholangiocarcinoma, gastric cancer, lymphocyte carcinoma, osteosarcoma, and canine cancer. PLB played anticancer activity many molecular mechanisms, such as targeting apoptosis, autophagy pathway, cell cycle arrest, antiangiogenesis pathway, anti-invasion, and antimetastasis pathway. Among these signaling pathways, the key regulatory genes regulated by PLB were NF-k, STAT3, and AKT. PLB also acted as a potent inducer of reactive oxygen species (ROS), suppressor of cellular glutathione, and novel proteasome inhibitor, causing DNA double-strand break by oxidative DNA base damage. This review comprehensively summarizes the anticancer activity and mechanism of PLB.
白花丹素(PLB)是从药用植物 L. 的根部分离得到的一种天然萘醌成分,对多种癌细胞系具有抗癌活性,包括乳腺癌、肝癌、白血病、黑色素瘤、前列腺癌、脑肿瘤、舌鳞癌、食管癌、口腔鳞癌、肺癌、肾腺癌、胆管癌、胃癌、淋巴细胞癌、骨肉瘤和犬癌。PLB 通过多种分子机制发挥抗癌活性,如靶向细胞凋亡、自噬途径、细胞周期停滞、抗血管生成途径、抗侵袭和抗转移途径。在这些信号通路中,PLB 调节的关键调节基因包括 NF-κB、STAT3 和 AKT。PLB 还作为活性氧(ROS)的有效诱导剂、细胞谷胱甘肽的抑制剂和新型蛋白酶体抑制剂,通过氧化 DNA 碱基损伤导致 DNA 双链断裂。本综述全面总结了 PLB 的抗癌活性和机制。